Consultation on Specialised Services clinical commissioning policies
NHS England has launched a 30 day public consultation on two proposed new clinical commissioning policies for specialised services – specifically Rituximab for the treatment of Primary Sjogren’s Syndrome (PSS) in adults, and Rituximab in Connective Tissue Disease associated Interstitial Lung Disease in adults. There has already been extensive engagement on these policies. They have […]